The tet regulatory system in which doxycycline (dox) acts as an inducer of specifically engineered RNA polymerase II promoters was transferred into transgenic mice. Tight control and a broad range of regulation spanning up to five orders of magnitude were monitored dependent on the dox concentration in the water supply of the animals. Administration of dox rapidly induces the synthesis of the indicator enzyme luciferase whose activity rises over several orders of magnitude within the first 4 h in some organs. Induction is complete after 24 h in most organs analyzed. A comparable regulatory potential was revealed with the tet regulatory system where dox prevents transcription activation. Directing the synthesis of the tetracycline-controlled transactivator (tTA) to the liver led to highly specific regula- A "genetic switch" that could be operated at will and that would permit the control of individual gene activities quantitatively and reversibly in a temporal and spatial manner would thus be of great advantage. The tetracycline (Tc)-controlled systems for the activation of transcription (7, 8) fulfill a number of these requirements at the cellular level. Herein, we report that the "reverse Tc-controlled transactivator" (rtTA) system, where doxycycline (dox) acts as an inducer of transcription as well as the "Tc-controlled transactivator" (tTA) system, where Tc or dox prevent transcription activation (Fig. 1) can be operated in a quantitative and highly tissue-specific way when transferred into mice. The results show that the controls are tight and that the kinetics of induction, especially with the rtTA system, are rapid. Although we (9, 10) and others (11, 12) have reported that the tTA system can be applied to transgenic organisms, the results reported herein establish that both the rtTA and the tTA systems provide true genetic switches capable of quantitatively controlling individual gene activities in animals in a highly tissue-specific manner. These observations open up exciting prospects for the study of gene function in mammalian organisms. Transgenic Animals. Transgenic mouse lines (NMRI outbred) were generated by pronuclear injection using standard techniques (14) and analyzed by the Southern blot technique (15) using the BamHI-EcoRV fragment of the luciferase gene and the XbaI fragment of the tTA gene as respective probes. Luciferase reporter mice were obtained upon transfer of the 3.1-kb XhoI-EaeI fragment of pUHC13-3 (7). Mice producing rtTA controlled by PhCMV, the promoter of the human cytomegalovirus immediate early genes, were obtained upon transfer of the 2.7-kb PflMI-XhoI fragment and animals synthesizing tTA under the control of the LAP promoter were obtained by transferring the 5.5-kbAseI-Asp700 fragment of pUHG15-30. Animals transgenic for both a transactivator and a reporter unit were exposed when necessary to doxycycline hydrochloride (Sigma) dissolved in 5% sucrose supplied as drinking water, which was exchanged every 3 days. Possible long-term effects of dox (200 ,ug/ml) were examined in a 3-month trial.
molecule of luciferase was detected per cell. By contrast, a more than 105-fold activation of the luciferase gene was observed in the absence of the antibiotic. This regulation was homogeneous throughout but stringently restricted to hepatocytes. These results demonstrate that both tetracyclinecontrolled transcriptional activation systems provide genetic switches that permit the quantitative control of gene activities in transgenic mice in a tissue-specific manner and, thus, suggest possibilities for the generation of a novel type of conditional mutants.
Most insights into gene function have been gained from the study of organisms susceptible to both efficient genetic dissections and biochemical analysis. Higher eukaryotes and particularly mammals do not belong to this category. The complexity of the genome, embryonic development, long generation times, and the difficulty of studying large numbers of individuals make the genetic analysis of these systems difficult, if not impossible. The technique of gene targeting in mice (1) has been an important breakthrough, but the irreversibility of the mutational alterations, which may lead to compensatory developments, developmental defects, and even embryonic mortality, limit this approach. One way to partially overcome such limitations is gene targeting with the sitespecific Cre/lox recombination system (2) as pioneered by Byrne and Ruddle (3) , by Westphal and coworkers (4) , and particularly by K. Rajewsky and coworkers (5, 6) . In this strategy, the CRE recombinase, controlled by an appropriate promoter, is used to activate, inactivate, or alter a gene during a defined differentiated state of cells in the developing organism. Again, however, the genetic changes are irreversible and follow a program that cannot be influenced after its onset.
A "genetic switch" that could be operated at will and that would permit the control of individual gene activities quantitatively and reversibly in a temporal and spatial manner would thus be of great advantage. The tetracycline (Tc)-controlled systems for the activation of transcription (7, 8) fulfill a number of these requirements at the cellular level. Herein, we report that the "reverse Tc-controlled transactivator" (rtTA) system, where doxycycline (dox) acts as an inducer of transcription as well as the "Tc-controlled transactivator" (tTA) system, where Tc or dox prevent transcription activation ( Fig. 1) can be operated in a quantitative and highly tissue-specific way when transferred into mice. The results show that the controls are tight and that the kinetics of induction, especially with the rtTA system, are rapid. Although we (9, 10) and others (11, 12) have reported that the tTA system can be applied to transgenic organisms, the results reported herein establish that both the rtTA and the tTA systems provide true genetic switches capable of quantitatively controlling individual gene activities in animals in a highly tissue-specific manner. These observations open up exciting prospects for the study of gene function in mammalian organisms.
MATERIALS AND METHODS
Plasmid Constructs. Plasmid pUHG17-1 is derived from pUHD17-1 (8) by replacing the simian virus 40 poly(A) signal with the 03-globin intron poly(A) signal. The liver-specific tTA expression plasmid pUHG15-30 contains the tTA gene under the control of PLAP, the promoter of the liver-enriched activator protein. It was obtained by cloning a 2.9-kb EcoRI-ApaI fragment containing the LAP promoter (13) in front of the tTA gene of pUHG15-1 (10). For details, see http://ix.urz.uniheidelberg.de/-q35/.
Transgenic Animals. Transgenic mouse lines (NMRI outbred) were generated by pronuclear injection using standard techniques (14) and analyzed by the Southern blot technique (15) using the BamHI-EcoRV fragment of the luciferase gene and the XbaI fragment of the tTA gene as respective probes. Luciferase reporter mice were obtained upon transfer of the 3.1-kb XhoI-EaeI fragment of pUHC13-3 (7). Mice producing rtTA controlled by PhCMV, the promoter of the human cytomegalovirus immediate early genes, were obtained upon transfer of the 2.7-kb PflMI-XhoI fragment and animals synthesizing tTA under the control of the LAP promoter were obtained by transferring the 5.5-kbAseI-Asp700 fragment of pUHG15-30. Animals transgenic for both a transactivator and a reporter unit were exposed when necessary to doxycycline hydrochloride (Sigma) dissolved in 5% sucrose supplied as drinking water, which was exchanged every 3 days. Possible long-term effects of dox (200 ,ug/ml) were examined in a 3-month trial.
Abbreviations: Tc, tetracycline; rtTA, reverse Tc-controlled transactivator; tTA, Tc-controlled transactivator; dox, doxycycline; rlu, relative light unit(s). to oligonucleotide (19) . Tissue samples were fixed with 4% paraformaldehyde in PBS, perfused with 30% sucrose, and frozen on dry ice. Hybridization and autoradiography were carried out on cryosections mounted onto poly-(L-lysine)-coated slides as described (19) . To detect lacZ expression, tissue samples were prepared and 4-bromo-3-chloro-2-indolyl j3-D-galactoside staining was performed as described (14) .
RESULTS
Experimental Strategy. To delineate the potential of the Tc-controlled activation via rtTA or tTA in transgenic mice, indicator mouse lines carrying the luciferase gene as a highly sensitive indicator function under the control of a rtTA/tTAresponsive promoter were generated as well as animals producing rtTA or tTA under the control of two different promoters. Crossbreeding of rtTA-or tTA-producing animals with "indicator mice" should lead to offsprings where induction factors, induction kinetics, and tissue specificity of expression could be studied. The promoters used to direct the synthesis of rtTA and tTA were PhCMv, the human cytomegalovirus immediate early promoter (20) , and PLAP the promoter responsible for the expression of the LAP (C/EBP,B) transcription factor in the liver of rats (13) . While PhCMV would direct rtTA or tTA synthesis to a variety of organs, PLAP was expected to function in the liver where its activity was restricted to parenchymal hepatocytes (U. Schibler and P. Fonjallaz, personal communication).
Generation of Luciferase Reporter Mouse Lines. The luciferase gene controlled by PhCMv*-l (7) was transferred into mice by pronucleus injection. Of 38 potential founder animals, Southern blot analysis revealed 10 (LO to L9) carrying the transgene. A low luciferase activity was detected in the tail tissue of 6 animals. When cultures of primary ear fibroblast from the 10 founders were transfected with tTA-expressing DNA (pUHD15-1; ref. 7), 7 showed Tc-dependent stimulation of luciferase activity (21) of which 5 transmitted the transgene. Monitoring the luciferase activity in 12 organs of these lines revealed line L7 where the basal luciferase activity was very low and constituted a characteristic and stable pattern (see Fig. 4 ). The lowest basal activity was found in liver and pancreas (s0.03 rlu/gsg of protein). Absolute determination of the luciferase in the liver of L7 animals showed that <1 molecule of the enzyme is present per hepatocyte. The highest background was found in the tongue and exceeded that of the liver about 100-fold when organ extracts were normalized to the protein content.
Identification In all four, the two rtTA-and the two tTA-producing mouse lines, the synthesis of the Tc-controlled transactivators was directed by PhCMV. Consequently, rtTA/tTA-dependent regulation was observed primarily in those organs/tissues where this promoter is known to be active-e.g., in muscle, kidney, thymus (22) , and pancreas but not in, e.g., liver, lung, and lymphocytes (M.G. and A.K., unpublished results).
Dox-Dependent Regulation of Luciferase Activity. The effect of dox on luciferase synthesis in double transgenic mice (i.e., rTAcMv3/L7, rTACMv4/L7, and TACMvl/L7) was measured after exposing the animals for 1 week to dox (2 mg/ml) in the drinking water. When the rTACMv3/L7 and rTACMv4/L7 animals were analyzed, two remarkable results were obtained. (i) In absence of dox, luciferase expression was indistinguishable from that of the L7 line in all organs analyzed except for two rTACMv4/L7 animals that showed slightly elevated values in the kidney (Fig. 2A) . This demonstrates that the presence of rtTA does not cause an intrinsic elevation of the background. (ii) In presence of dox, luciferase synthesis was induced over several orders of magnitude depending on the organ/tissue. Up to a 105-fold induction was observed in the pancreas but high luciferase values were also found, e.g., in muscle, stomach, and thymus. Both mouse lines, rTACMv3 and rTACMv4, produced very similar patterns ( Fig. 2A) reflecting the activity of PhCMV in various tissues of transgenic mice. Little or no activity was found in lung, brain, liver, and lymphocytes, never exceeding 7 rlu/,ug of protein.
As expected, the opposite effect of dox was observed with TACMvl/L7 animals. In absence of the antibiotic, luciferase was highly induced, again following the tissue pattern of PhcMv activity in mice (Fig. 2B) . Administration of dox reduces the activity of luciferase to background levels in most organs and in pancreas, a regulation factor of almost 105 was again reached.
Time Course ofLuciferase Induction and Partial Activation.
To study the kinetics of luciferase induction in rTACMv3/L7 mice, animals were switched to dox-containing drinking water and sacrificed after 4, 9, and 24 h for determining luciferase activity in various organs. Significant induction was observed after 4 h in most organs analyzed, and full induction was generally achieved after 24 h (Fig. 3A) . When the time course of induction was followed in TACMvl/L7 mice, the animals were kept at the lowest concentration of dox, 20 ,ug/ml, shown to prevent tTA-dependent activation in all organs except skeletal muscle (Fig. 3A) . Upon withdrawal of the antibiotic in the water supply, significant induction was found after 24 h in several organs, particularly in tongue, heart, thymus, and pancreas, and almost full activation was monitored after 1 week. As expected, induction of the rtTA system was more rapid since it does not rely to the same extent on the biological half-life of dox in the animal. Partial activation of luciferase synthesis by limiting amounts of dox was achieved by exposing TAcMvl/L7 animals to increasing concentrations of dox in the drinking water for 1 week. While tTA action was still prevented with dox at 20 ,ug/ml in all organs except skeletal muscle, concentrations of 2 ,ug/ml and 200 ng/ml led to different levels of activity, however, in an organ-dependent manner. As exemplified in genic animals TALAP1/L7 and TALAP2/L7 showed very high levels of luciferase activity in the liver that were reduced to background activity when the animals were exposed to dox at 2 mg/ml in the drinking water (Fig. 4) activity of TALAP2/L7 animals was 200-(spleen) to 10,000-fold lower than in the liver whereby in a number of organs this activity was identical to the L7 background (Fig. 4) . A relatively high luciferase activity was monitored in the brain of TALAP1/L7 animals.
In situ hybridization of oligonucleotide probes directed towards mRNA of tTA or luciferase revealed a homogeneous staining of livers of TALAP1/L7 mice in absence of dox ( Fig.  SA and B) whereas in its presence, luciferase-specific RNA was not detectable (Fig. 5B) . When TALAP1 mice were crossed with a mouse line containing the ,B-galactosidase gene under the control of PhCMv*-l (J.J., P. Seeburg, and R. Sprengel, unpublished results), liver sections of animals carrying both transgenes showed a homogeneous staining of hepatocytes in the absence of dox whereby no 13-galactosidase activity was detected in cells constituting, e.g., capillary vessels (21) . f3-Galactosidase activity was eliminated when the animals were kept under dox (Fig. SC) . In sections of other tissues as exemplified for a brain region (Fig. SD) , ,f-galactosidase was not detectable independent of the absence or presence of dox.
DISCUSSION
The results reported herein show that the rtTA-as well as the tTA-based regulatory system permits the control of gene activities in transgenic mice over a wide range and that "off-states" can be achieved that appear equivalent to null mutations. Moreover, induction in many organs is rapid, particularly with the rtTA system. As in HeLa cells (7, 8) and in tobacco plants (9) , the tet systems exhibit no measurable "intrinsic leakiness." Instead, the background activities, which are sometimes observed, reflect activation from outside and depend on the chromosomal site where a gene controlled by a rtTA/tTA-responsive promoter is integrated. Interestingly, infrequent. The first examples for such functionally defined loci are the integration sites of the luciferase gene in the Xl and X2 HeLa cell lines (7) that, in presence of dox, produce less than seven molecules of luciferase per cell (M.G., A. Bonin, and A.K., unpublished results) while a more than 105-fold induction occurs in the absence of the antibiotic. Another example is provided by the L7 mouse line, where very low luciferase activities are monitored in all organs, particularly in liver, pancreas, and lymphocytes (data not shown). Less than one molecule of the enzyme per cell was calculated by relating the luciferase activity in liver extracts to the number of hepatocytes of the starting material. This indicates that also in other organs where up to 100 times higher luciferase activities were measured (normalized to the protein content of the extracts), extremely low background activity must prevail. This "L7 locus" is activatable in all organs/tissues where rtTA or tTA was synthesized: in addition to the 12 organs shown in Fig.  4 , the locus functions in various areas of the brain and in lymphocytes (21) , suggesting that it is accessible for rtTA/tTA in most, if not all cell types.
When the synthesis of rtTA is directed by the PhCMV, activation of luciferase in presence of dox is observed in a number of tissues/organs (Fig. 2A) . The highest activation factors exceeding five orders of magnitude are measured in the pancreas but luciferase activity is increased also in other organs 102-to 104-fold. An identical pattern of activation is obtained with two PhCMV-controlled tTA mouse lines of which one is shown in Fig. 2B . Again, an about 105-fold activation is monitored in the pancreas and high activities are measured also in stomach and skeletal muscle. We interpret the different levels of activation in various organs as reflecting the activity of PhCMV in different cell types. This is supported by results obtained with other rtTA-and tTA-producing mouse lines (TACMv2, TACMV4, and rTAcMv2), where the same relative pattern of activity throughout the organs is detected but at 10-to 1000-fold lower levels. The only organ in all animals where dox did not fully reduce tTA activity to background level under the conditions used is skeletal muscle. This deserves further analysis since it contradicts earlier observations (24) .
Animals where the transactivator synthesis was specified by
PhCMV appeared particularly useful for studying kinetics of induction and partial induction. These would allow measurement of kinetics parameters in different organs where the pharmacokinetic properties of dox might generate different results. As shown in Fig. 3A , rapid induction in rTACMV3/L7 mice is achieved upon supply of dox. In some organs (pancreas, kidney, and thymus), luciferase activity is elevated already after 4 h and in most organs induction is complete after 24 h. These data delineate lower limits of induction kinetics since there are more efficient techniques for administering dox than the oral route. As expected, induction via the tTA system (TACMv1/L7 animals, Fig. 3A ) is slower, since herein the effector molecule has to be withdrawn and, consequently, the biological half-life of the antibiotic is a decisive parameter. Thus, while in several organs (pancreas, thymus, heart, and tongue) elevated luciferase levels are seen after 24 h, full induction may take 4-7 days in some organs. In such experiments, it is important to keep the animals initially at the lowest effective dox concentration, which in our experience is 20 ,ug/ml in the water supply (Fig. 3A) (25) . Tetracyclines with different biological half-life and compounds acting as Tc antagonists would certainly be useful to accelerate this induction process. Organ specificity was also observed when partial induction at different dox concentrations was examined, as exemplified for three organs in Fig. 3B . These data strongly suggest that tissue/organ-specific calibrations are necessary to define conditions proper for partial activation of a gene in a given tissue. With the rtTA system, partial induction between 6% and 53% was observed in various organs when the dox concentration in the drinking water was reduced from 2 mg/ml to 200 ,ug/ml (21).
The full potential of the tet regulatory systems becomes evident in experiments where the synthesis of tTA was directed to the liver by PLAP. A particularly high tissue specificity of tTA synthesis is achieved in the LT2 mouse line. When crossed with L7 animals whose luciferase background in the liver is lowest, activation of luciferase exceeding five orders of magnitude is measured in that organ, two to four orders of magnitude higher than in any other organ.
In situ hybridization reveals an even distribution of mRNA of tTA as well as of luciferase throughout the organ and only the luciferase RNA synthesis is sensitive to the presence of dox. Proc. Natl. Acad. Sci. USA 93 (1996) SC), whereas cells of vessels and connective tissue show no ,3-galactosidase activity (21) . In presence of dox, an equally homogeneous shut off of j3-galactosidase synthesis is seen. There is no sign of "mosaic expression" as discussed in other reports (10, 26) . Since in the latter studies viral promoters were used to drive tTA synthesis, the observed phenomenon is most likely due to specific properties of such promoters as described (27) .
The main conclusion from our findings is that the tet regulatory systems indeed permit the tight and tissue-specific control of individual genes in higher organisms, provided certain prerequisites are met. Given proper rtTA/tTAresponsive promoters, tightness of an expression unit depends on the site of chromosomal integration. The further characterization of such chromosomal sites for gene targeting will, therefore, be of interest. Similarly, since the tissue-specific synthesis of rtTA or tTA depends on the proper combinations of promoter and chromosomal integration site, such combinations have to be identified. For hepatocyte-specific regulation, the combination of PLAP with the locus of the TALAP1 line already appears to be an excellent solution. Although it may be difficult at present to find such combinations for a particular question, mouse lines where Tc-controlled transactivators are synthesized tissue-specifically in the liver (TALAP2), in heart muscle (11), or in pancreatic f cells (12) 
